次生代谢产物作为代谢紊乱和传染病的首选治疗方法及其代谢谱分析：第1部分。 - Suppr

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling: Part 1.

作者信息

Singla Rajeev K

机构信息

Institutes for Systems Genetics Frontiers Science Center for Disease-related Molecular Network West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

出版信息

Curr Drug Metab. 2020;21(7):480-481. doi: 10.2174/138920022107200925101631.

DOI:10.2174/138920022107200925101631

PMID:33172364

Abstract

摘要

相似文献

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling: Part 1.

Curr Drug Metab. 2020;21(7):480-481. doi: 10.2174/138920022107200925101631.

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases & their Metabolic Profiling-Part 2.

Curr Drug Metab. 2020;21(14):1070-1071. doi: 10.2174/138920022114201230142204.

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling - Part 3.

Curr Drug Metab. 2021;22(6):412-414. doi: 10.2174/138920022206210708103019.

Natural Bioactive Compounds Acting against Oxidative Stress in Chronic, Degenerative, and Infectious Diseases.

Oxid Med Cell Longev. 2018 Dec 3;2018:3894381. doi: 10.1155/2018/3894381. eCollection 2018.

Editorial (Thematic Issue: Natural Leads in Drug Discovery against Metabolic Disorders and their Related Infectious Diseases).

Curr Top Med Chem. 2016;16(23):2523-4. doi: 10.2174/1568026616999160510121418.

Secondary Metabolites in the Treatment of Diabetes Mellitus: A Paradigm Shift.

Curr Drug Metab. 2020;21(7):493-511. doi: 10.2174/1389200221666200514081947.

Natural Products as Clinically Important Enzyme Inhibitors.

Comb Chem High Throughput Screen. 2020;23(9):915-916. doi: 10.2174/138620732309201127105658.

[Artemisinin: a natural product for fighting against cancer].

Nihon Yakurigaku Zasshi. 2014 Feb;143(2):61-4. doi: 10.1254/fpj.143.61.

Natural products as modulator of autophagy with potential clinical prospects.

Apoptosis. 2017 Mar;22(3):325-356. doi: 10.1007/s10495-016-1335-1.

Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases.

Nat Prod Rep. 2011 Mar;28(3):543-93. doi: 10.1039/c0np00059k. Epub 2011 Feb 2.

引用本文的文献

Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.

Front Pharmacol. 2022 Feb 21;13:801733. doi: 10.3389/fphar.2022.801733. eCollection 2022.

Natural Products for the Management of Castration-Resistant Prostate Cancer: Special Focus on Nanoparticles Based Studies.

Front Cell Dev Biol. 2021 Nov 5;9:745177. doi: 10.3389/fcell.2021.745177. eCollection 2021.

Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies.

Front Pharmacol. 2021 Oct 19;12:732266. doi: 10.3389/fphar.2021.732266. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling: Part 1.

作者信息

Singla Rajeev K

机构信息

Institutes for Systems Genetics Frontiers Science Center for Disease-related Molecular Network West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.